BDBM50226606 (S)-2-(2-aminoethylamino)-3-(1-propyl-1H-imidazol-4-yl)propanoic acid::CHEMBL236547
SMILES: CCCn1cnc(C[C@H](NCCN)C(O)=O)c1
InChI Key: InChIKey=UVTMXVBQOPVNHA-JTQLQIEISA-N
Data: 3 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carboxypeptidase B2 isoform A (Homo sapiens (Human)) | BDBM50226606 ((S)-2-(2-aminoethylamino)-3-(1-propyl-1H-imidazol-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 84 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development Curated by ChEMBL | Assay Description Inhibition of human TAFIa | J Med Chem 50: 6095-103 (2007) Article DOI: 10.1021/jm0702433 BindingDB Entry DOI: 10.7270/Q2T153CG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 isoform A (Homo sapiens (Human)) | BDBM50226606 ((S)-2-(2-aminoethylamino)-3-(1-propyl-1H-imidazol-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 150 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development Curated by ChEMBL | Assay Description Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 mins | Bioorg Med Chem Lett 20: 92-6 (2010) Article DOI: 10.1016/j.bmcl.2009.11.029 BindingDB Entry DOI: 10.7270/Q2J1038R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin-activatable fibrinolysis (TAFI) (Homo sapiens (Human)) | BDBM50226606 ((S)-2-(2-aminoethylamino)-3-(1-propyl-1H-imidazol-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 1.16E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development Curated by ChEMBL | Assay Description Inhibition of human pancreatic carboxypeptidase B | Bioorg Med Chem Lett 20: 92-6 (2010) Article DOI: 10.1016/j.bmcl.2009.11.029 BindingDB Entry DOI: 10.7270/Q2J1038R | |||||||||||
More data for this Ligand-Target Pair |